Model-informed precision dosing-guided limited sampling strategies are feasible for estimation of current exposure using similar sampling times for mycophenolic acid and tacrolimus and accurate long-term prediction is not possible, underscoring the need for repeated therapeutic drug monitoring.
Astrid Heida, E. Cornelissen, R. Aarnoutse et al.· Clinical Pharmacokinetics· 0 citations
Aminoglycosides require therapeutic drug monitoring due to substantial pharmacokinetic variability across individuals. While population pharmacokinetic (popPK) models have been developed for individual drugs across age groups, and cross‐drug maturation models have been explored, it is unclear whether pooling data acros...
Dominic M. H. Tong, Jonathan D. Faldasz, R. J. Keizer et al.· Journal of clinical pharmaco...· 0 citations
Interleukin (IL)-23p19 inhibitors are increasingly used in immune-mediated inflammatory diseases (IMIDs), particularly inflammatory bowel disease (IBD). Almost half of patients show inadequate response, partly due to pharmacokinetic (PK) variability. However, a comprehensive overview of their PK parameters is lacking,...
I. A. Pool, Alise D. E. de Groot, R. J. Keizer et al.· Clinical Pharmacokinetics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.